Similar articles for PMID: 31227874

Year	Number of Results
1993	2
1996	1
1999	2
2000	2
2001	1
2004	1
2005	2
2006	1
2007	2
2008	3
2009	6
2010	4
2011	5
2012	7
2013	5
2014	9
2015	11
2016	19
2017	13
2018	9
2019	9
2020	8
2021	5
2022	6
2023	1
2024	0

1

Predictors of responders for low-dose carperitide monotherapy in patients with acute heart failure.

Kamiya M, Sato N, Matsuda J, Nozaki A, Akiya M, Sato T, Okazaki H, Takahashi Y, Shimizu W. Kamiya M, et al. Heart Vessels. 2020 Jan;35(1):59-68. doi: 10.1007/s00380-019-01450-w. Epub 2019 Jun 21. Heart Vessels. 2020. PMID: 31227874

2

Predictors of Worsening Renal Function in Patients With Acute Decompensated Heart Failure Treated by Low-Dose Carperitide.

Kawase Y, Kadota K, Tada T, Hata R, Iwasaki K, Maruo T, Katoh H, Mitsudo K. Kawase Y, et al. Circ J. 2016;80(2):418-25. doi: 10.1253/circj.CJ-15-0928. Epub 2015 Dec 15. Circ J. 2016. PMID: 26667591 Free article.

3

Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide.

Kamiya M, Sato N, Nozaki A, Akiya M, Okazaki H, Takahashi Y, Mizuno K, Shimizu W. Kamiya M, et al. J Cardiovasc Pharmacol. 2015 Mar;65(3):282-8. doi: 10.1097/FJC.0000000000000193. J Cardiovasc Pharmacol. 2015. PMID: 25748698 Clinical Trial.

4

Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study.

Nomura F, Kurobe N, Mori Y, Hikita A, Kawai M, Suwa M, Okutani Y. Nomura F, et al. Circ J. 2008 Nov;72(11):1777-86. doi: 10.1253/circj.cj-07-0760. Epub 2008 Oct 3. Circ J. 2008. PMID: 18832779 Free article. Clinical Trial.

5

Systolic blood pressure at admission as a predictor of the response to initial carperitide therapy in patients hospitalized for acute decompensated heart failure with left ventricular systolic dysfunction.

Kajimoto K, Sashida Y, Minami Y, Yumino D, Kawarai H, Kasanuki H. Kajimoto K, et al. Cardiovasc Drugs Ther. 2009 Dec;23(6):481-8. doi: 10.1007/s10557-009-6207-2. Cardiovasc Drugs Ther. 2009. PMID: 19937464 Clinical Trial.

6

Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study.

Okuhara Y, Asakura M, Azuma K, Orihara Y, Nishimura K, Ando T, Kondo H, Naito Y, Kashiwase K, Hirotani S, Ishihara M, Masuyama T. Okuhara Y, et al. PLoS One. 2018 Jun 18;13(6):e0199263. doi: 10.1371/journal.pone.0199263. eCollection 2018. PLoS One. 2018. PMID: 29912952 Free PMC article.

7

Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure.

Kula AJ, Hanberg JS, Wilson FP, Brisco MA, Bellumkonda L, Jacoby D, Coca SG, Parikh CR, Tang WHW, Testani JM. Kula AJ, et al. Circ Heart Fail. 2016 Jan;9(1):e002333. doi: 10.1161/CIRCHEARTFAILURE.115.002333. Epub 2015 Dec 23. Circ Heart Fail. 2016. PMID: 26699390 Free PMC article.

8

Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF).

Nagai T, Honda Y, Nakano H, Honda S, Iwakami N, Mizuno A, Komiyama N, Yamane T, Furukawa Y, Miyagi T, Nishihara S, Tanaka N, Adachi T, Hamasaki T, Asaumi Y, Tahara Y, Aiba T, Sugano Y, Kanzaki H, Noguchi T, Kusano K, Yasuda S, Ogawa H, Anzai T. Nagai T, et al. Cardiovasc Drugs Ther. 2017 Dec;31(5-6):551-557. doi: 10.1007/s10557-017-6760-z. Cardiovasc Drugs Ther. 2017. PMID: 29098501

9

Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure.

Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Abe Y, Saito T, Ohwada T, Suzuki H, Saitoh S, Kubota I, Takeishi Y; AVCMA investigators. Suzuki S, et al. Int Heart J. 2015;56(2):213-8. doi: 10.1536/ihj.14-248. Epub 2015 Feb 23. Int Heart J. 2015. PMID: 25740399 Free article. Clinical Trial.

10

Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study.

Hata N, Seino Y, Tsutamoto T, Hiramitsu S, Kaneko N, Yoshikawa T, Yokoyama H, Tanaka K, Mizuno K, Nejima J, Kinoshita M. Hata N, et al. Circ J. 2008 Nov;72(11):1787-93. doi: 10.1253/circj.cj-08-0130. Epub 2008 Sep 24. Circ J. 2008. PMID: 18812677 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

117 results

Results by year